Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04105881
Other study ID # Dear
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 10, 2020
Est. completion date March 15, 2020

Study information

Verified date September 2019
Source Assiut University
Contact Khalid Hassanein, Professor
Phone +20109191208
Email Khaledhassanein70@aun.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

During pregnancy , the maternal immune system is always confronted with fetal alloantigens. the immunological mechanisms that prevent the rejection of the fetus are still not under understood.


Description:

During pregnancy , the maternal immune system is always confronted with fetal alloantigens. the immunological mechanisms that prevent the rejection of the fetus are still not under understood.the fetus is normally accepted by the maternal immune system despite despite the expression of paternal alloantigens. Normally, the fetus grows and develops very well with ongoing pregnancy.

B regulatory cells are increased in pregnant women compared to non-pregnant women.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date March 15, 2020
Est. primary completion date March 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- healthy female according to the required groups

Exclusion Criteria:

- patient with infectious disease , tuberculosis ,tumor ,hematologic disease,metabolic bone disease or any other connective tissue diseases were excluded.

- Patient with viral hepatitis.

- serological evidence of HIV infection.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Investigation
Cross sectional intervention

Locations

Country Name City State
Egypt Assiut university Assiut
Egypt Assiut university Asyut Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (2)

Lima J, Martins C, Leandro MJ, Nunes G, Sousa MJ, Branco JC, Borrego LM. Characterization of B cells in healthy pregnant women from late pregnancy to post-partum: a prospective observational study. BMC Pregnancy Childbirth. 2016 Jun 6;16(1):139. doi: 10.1 — View Citation

Zahran AM, Zharan KM, Hetta HF. Significant correlation between regulatory T cells and vitamin D status in term and preterm labor. J Reprod Immunol. 2018 Sep;129:15-22. doi: 10.1016/j.jri.2018.07.004. Epub 2018 Jul 18. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in number of B regulatory cell in pregnant woman Immune system immunosuppressed to maintain fetus 9 months
See also
  Status Clinical Trial Phase
Completed NCT03171480 - Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia Phase 4
Completed NCT00397735 - N-acetylcysteine in Intra-amniotic Infection/Inflammation Phase 1/Phase 2
Completed NCT00209326 - A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor Phase 2
Terminated NCT03682822 - Routine Early vs Delayed Amniotomy for Preterm Pregnancies: A Randomized Open Label Trial N/A
Terminated NCT00137501 - Two Dose Regimens of Nifedipine for the Management of Preterm Labor Phase 3
Terminated NCT00641784 - Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population Phase 3
Withdrawn NCT01206998 - Vaginal Progesterone as a Treatment for Women Active Preterm Labor N/A
Completed NCT00599898 - Nifedipine Compared to Atosiban for Treating Preterm Labor Phase 4
Completed NCT00059683 - Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk Women N/A
Completed NCT00432250 - The Use of Cervical Length to Reduce Hospital Stay in Women Admitted Because of Preterm Labor. Phase 4
Terminated NCT00116623 - Magnesium Sulfate Versus Indomethacin for Preterm Labor Phase 4